196 related articles for article (PubMed ID: 26678977)
1. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
Swalchick W; Shamekh R; Bui MM
Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
[TBL] [Abstract][Full Text] [Related]
2. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
[TBL] [Abstract][Full Text] [Related]
3. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
[TBL] [Abstract][Full Text] [Related]
4. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies.
Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340
[TBL] [Abstract][Full Text] [Related]
5. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.
Dailey DD; Ehrhart EJ; Duval DL; Bass T; Powers BE
J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711
[TBL] [Abstract][Full Text] [Related]
6. [The role of the DOG1 antibody in the diagnosis of gastrointestinal stromal tumours - GIST].
Gutierrez MR; Dorronsoro ML; Marco AM; Pérez IR; Villegas IA; Virseda JM
An Sist Sanit Navar; 2011; 34(2):245-51. PubMed ID: 21904406
[TBL] [Abstract][Full Text] [Related]
7. Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.
Li J; Zhang H; Lu Y; Chen Z; Su K
Int J Clin Exp Pathol; 2015; 8(5):5721-6. PubMed ID: 26191287
[TBL] [Abstract][Full Text] [Related]
8. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
9. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
Sui XL; Wang H; Sun XW
Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
[TBL] [Abstract][Full Text] [Related]
10. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.
Lee CH; Liang CW; Espinosa I
Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677
[TBL] [Abstract][Full Text] [Related]
11. DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.
Simon S; Grabellus F; Ferrera L; Galietta L; Schwindenhammer B; Mühlenberg T; Taeger G; Eilers G; Treckmann J; Breitenbuecher F; Schuler M; Taguchi T; Fletcher JA; Bauer S
Cancer Res; 2013 Jun; 73(12):3661-70. PubMed ID: 23576565
[TBL] [Abstract][Full Text] [Related]
12. DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.
Wada T; Tanabe S; Ishido K; Higuchi K; Sasaki T; Katada C; Azuma M; Naruke A; Kim M; Koizumi W; Mikami T
World J Gastroenterol; 2013 Dec; 19(47):9133-6. PubMed ID: 24379641
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
14. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M
Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
[TBL] [Abstract][Full Text] [Related]
15. A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma.
Riddle ND; Gonzalez RJ; Bridge JA; Antonia S; Bui MM
Cancer Control; 2011 Jul; 18(3):152-9. PubMed ID: 21666577
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker.
Ardeleanu C; Arsene D; Hinescu M; Andrei F; Gutu D; Luca L; Popescu LM
Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):413-8. PubMed ID: 19417627
[TBL] [Abstract][Full Text] [Related]
17. Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).
Miwa S; Nakajima T; Murai Y; Takano Y; Sugiyama T
J Gastroenterol; 2008; 43(7):531-7. PubMed ID: 18648740
[TBL] [Abstract][Full Text] [Related]
18. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A
Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018
[TBL] [Abstract][Full Text] [Related]
19. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
[TBL] [Abstract][Full Text] [Related]
20. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors.
Kang GH; Srivastava A; Kim YE; Park HJ; Park CK; Sohn TS; Kim S; Kang DY; Kim KM
Mod Pathol; 2011 Jun; 24(6):866-75. PubMed ID: 21358619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
